Collectively, these technologies illustrate the transition from native proteins to highly engineered biobetters with optimized pharmacological profiles and clinical outcomes
The person-to-person transmission landscape of the gut and oral microbiomes
Effect of oral semaglutide on energy intake, appetite, control of eating and gastric emptying in adults living with obesity: A randomized controlled trial
Straightforward Access to Medical Weight Care Medication pricing (starting at): A Deeper, Root-Cause Approach to Weight & Metabolism Medication pricing (starting at): Advanced, Cash-Pay Metabolic & Peptide Care Medication pricing (starting at): Hear directly from our providers on how to lose weight the right way, managing your metabolic health, and supporting long-term success.
* Oculis's privosegtor (OCS-05) is entering Phase 3 trials for acute optic neuritis (AON) and non-arteritic anterior ischemic optic neuropathy (NAION), addressing significant unmet medical needs in neuro-ophthalmology
The treatment takes about 60-90 minutes and requires specialized equipment and training